Anika Therapeutics, Inc. - ANIK

About Gravity Analytica
Recent News
- 06.09.2026 - Osteoarthritis and Inflammation: Understanding What’s Happening Inside the Joint
- 06.05.2026 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 05.21.2026 - What Is Cingal? A Proven Joint Injection for Osteoarthritis Pain
- 05.05.2026 - Can the Body Heal Joint Tissue on its Own?
- 04.30.2026 - The Science of Healing: How Biologic Scaffolds Support Your Body’s Recovery
- 04.29.2026 - Anika Reports First Quarter 2026 Financial Results
- 04.15.2026 - Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026
- 04.03.2026 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Recent Filings
- 06.08.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
- 06.05.2026 - 4 Statement of changes in beneficial ownership of securities
- 06.01.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
- 05.04.2026 - 4 Statement of changes in beneficial ownership of securities
- 04.30.2026 - 4 Statement of changes in beneficial ownership of securities
- 04.30.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 04.29.2026 - 8-K Current report
- 04.29.2026 - EX-99.1 EX-99.1
- 04.29.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
- 04.28.2026 - ARS Annual Report to Security Holders